Gregory K. Friedman
Department of Pediatrics, Division of Pediatrics
Present Title & Affiliation
Primary Appointment
Professor, Department of Pediatrics Patient Care, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2002 | Medical College of Georgia, Augusta, GA, USA, MD, Medicine |
| 1997 | College of William and Mary, Williamsburg, VA, USA, BA, Kinesiology |
Postgraduate Training
| 2005-2008 | Clinical Fellowship, Pediatric Hematology/Oncology, University of Alabama at Birmingham, Children's Hospital of Alabama, Birmingham, AL |
| 2003-2005 | Clinical Residency, Pediatrics, University of Alabama at Birmingham, Children's Hospital of Alabama, Birmingham, AL |
| 2002-2003 | Clinical Internship, Pediatrics, University of Alabama at Birmingham, Children's Hospital of Alabama,, Birmingham, AL |
Board Certifications
| 2009 | Pediatric Hematology and Oncology |
| 2005 | General Pediatrics |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Kang KD, Bernstock JD, Totsch SK, Gary SE, Rocco A, Nan L, Li R, Etminan T, Han X, Beierle EA, Eisemann T, Wechsler-Reya RJ, Bae S, Whitley R, Gillespie GY, Markert JM, Friedman GK. Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers. Clin Cancer Res 28(24):5419-5430, 2022. PMID: 36239623.
- Ghajar-Rahimi G, Kang KD, Totsch SK, Gary S, Rocco A, Blitz S, Kachurak K, Chambers MR, Li R, Beierle EA, Bag A, Johnston JM, Markert JM, Bernstock JD, Friedman GK. Clinical advances in oncolytic virotherapy for pediatric brain tumors. Pharmacol Ther 239:108193, 2022. e-Pub 2022. PMID: 35487285.
- Rosenberg T, Yeo KK, Mauguen A, Alexandrescu S, Prabhu SP, Tsai JW, Malinowski S, Joshirao M, Parikh K, Farouk Sait S, Rosenblum MK, Benhamida JK, Michaiel G, Tran HN, Dahiya S, Kachurak K, Friedman GK, Krystal JI, Huang MA, Margol AS, Wright KD, Aguilera D, MacDonald TJ, Chi SN, Karajannis MA. Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma. Neuro Oncol 24(11):1964-1975, 2022. PMID: 35397478.
- Bernstock JD, Kang KD, Klinger NV, Olsen HE, Gary S, Totsch SK, Ghajar-Rahimi G, Segar D, Thompson EM, Darley-Usmar V, Mott BT, Peruzzotti-Jametti L, Friedman GK. Targeting oncometabolism to maximize immunotherapy in malignant brain tumors. Oncogene 41(19):2663-2671, 2022. e-Pub 2022. PMID: 35430605.
- Friedman GK, Johnston JM, Bag AK, Bernstock JD, Li R, Aban I, Kachurak K, Nan L, Kang KD, Totsch S, Schlappi C, Martin AM, Pastakia D, McNall-Knapp R, Farouk Sait S, Khakoo Y, Karajannis MA, Woodling K, Palmer JD, Osorio DS, Leonard J, Abdelbaki MS, Madan-Swain A, Atkinson TP, Whitley RJ, Fiveash JB, Markert JM, Gillespie GY. Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas. N Engl J Med 384(17):1613-1622, 2021. e-Pub 2021. PMID: 33838625.
- Boyd NH, Tran AN, Bernstock JD, Etminan T, Jones AB, Gillespie GY, Friedman GK, Hjelmeland AB. Glioma stem cells and their roles within the hypoxic tumor microenvironment. Theranostics 11(2):665-683, 2021. e-Pub 2021. PMID: 33391498.
- Bernstock JD, Bag AK, Fiveash J, Kachurak K, Elsayed G, Chagoya G, Gessler F, Valdes PA, Madan-Swain A, Whitley R, Markert JM, Gillespie GY, Johnston JM, Friedman GK. Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors. Hum Gene Ther 31(19-20):1132-1139, 2020. e-Pub 2020. PMID: 32657154.
- Bhatia S, Chen Y, Wong FL, Hageman L, Smith K, Korf B, Cannon A, Leidy DJ, Paz A, Andress JE, Friedman GK, Metrock K, Neglia JP, Arnold M, Turcotte LM, de Blank P, Leisenring W, Armstrong GT, Robison LL, Clapp DW, Shannon K, Nakamura JL, Fisher MJ. Subsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1. J Clin Oncol 37(32):3050-3058, 2019. e-Pub 2019. PMID: 31532722.
- Totsch SK, Schlappi C, Kang KD, Ishizuka AS, Lynn GM, Fox B, Beierle EA, Whitley RJ, Markert JM, Gillespie GY, Bernstock JD, Friedman GK. Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance. Oncogene 38(34):6159-6171, 2019. e-Pub 2019. PMID: 31289361.
- Bernstock JD, Vicario N, Rong L, Valdes PA, Choi BD, Chen JA, DiToro D, Osorio DS, Kachurak K, Gessler F, Johnston JM, Atkinson TP, Whitley RJ, Bag AK, Gillespie GY, Markert JM, Maric D, Friedman GK. A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibition. Oncoimmunology 8(12):e1678921, 2019. e-Pub 2019. PMID: 31741780.
Patient Reviews
CV information above last modified May 06, 2024